Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 13 » default
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (601)
- Volume 16, 2023 (77)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Archive: Volume 13, 2020
Single-Nucleotide Polymorphisms in Genes Predisposing to Leprosy in Leprosy Household Contacts in Zhejiang Province, China
Shen YL, Long SY, Kong WM, Wu LM, Fei LJ, Yao Q, Wang HS
Pharmacogenomics and Personalized Medicine 2020, 13:767-773
Published Date: 21 December 2020
Screening and Identifying Cisplatin-Related Gene Mutations in Lung Squamous Cell Carcinoma
Li X, Wang Y, Hu S, Bai Y
Pharmacogenomics and Personalized Medicine 2020, 13:757-766
Published Date: 18 December 2020
Case–Control Study on TNFRSF6B Gene Polymorphism and Susceptibility to Gastric Cancer in a Chinese Han Population
Gu X, Mao Z, Pan H, Zou C, Ding G, Fan Y
Pharmacogenomics and Personalized Medicine 2020, 13:749-756
Published Date: 17 December 2020
A Novel Prognostic Score Based on ZG16 for Predicting CRC Survival
Wang W, Sun JF, Wang XZ, Ying HQ, You XH, Sun F
Pharmacogenomics and Personalized Medicine 2020, 13:735-747
Published Date: 16 December 2020
Association of IL-17 and IL-23 Gene Variants with Plasma Levels and Risk of Vulvovaginal Candidiasis in a Chinese Han Population
Li W, Shi W, Yin Y, Chen J, Luo L
Pharmacogenomics and Personalized Medicine 2020, 13:725-733
Published Date: 15 December 2020
Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation
Bright D, Saadeh C, DeVuyst-Miller S, Sohn M, Choker A, Langerveld A
Pharmacogenomics and Personalized Medicine 2020, 13:719-724
Published Date: 10 December 2020
A Seven-NF-κB-Related Gene Signature May Distinguish Patients with Ulcerative Colitis-Associated Colorectal Carcinoma
Ge CY, Wei LY, Tian Y, Wang HH
Pharmacogenomics and Personalized Medicine 2020, 13:707-718
Published Date: 2 December 2020
Identification of Novel Biomarkers for Predicting Kidney Injury Due to Drugs Using “Omic” Strategies
Awdishu L, Atilano-Roque A, Tuey S, Joy MS
Pharmacogenomics and Personalized Medicine 2020, 13:687-705
Published Date: 2 December 2020
Cystic Fibrosis Polymorphic Variants in a Russian Population
Kiseleva A, Klimushina M, Sotnikova E, Skirko O, Divashuk M, Kurilova O, Ershova A, Khlebus E, Zharikova A, Efimova I, Pokrovskaya M, Slominsky PA, Shalnova S, Meshkov A, Drapkina O
Pharmacogenomics and Personalized Medicine 2020, 13:679-686
Published Date: 1 December 2020
Association of MDM4 Gene rs4245739 Polymorphism with the Risk and Clinical Characteristics of Colorectal Cancer in a Chinese Han Population
Zhao DM, Diao YE, Xu Q
Pharmacogenomics and Personalized Medicine 2020, 13:673-678
Published Date: 26 November 2020
The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn’s Disease
Ha C, Kim ES, Kwon Y, Choe YH, Kim MJ, Lee SY
Pharmacogenomics and Personalized Medicine 2020, 13:665-671
Published Date: 26 November 2020
Impact of APOE Alleles-by-Diet Interactions on Glycemic and Lipid Features– A Cross-Sectional Study of a Cohort of Type 2 Diabetes Patients from Western Mexico: Implications for Personalized Medicine
Torres-Valadez R, Ramos-Lopez O, Frías Delgadillo KJ, Flores-García A, Rojas Carrillo E, Aguiar-García P, Bernal Pérez JA, Martinez-Lopez E, Martínez JA, Zepeda-Carrillo EA
Pharmacogenomics and Personalized Medicine 2020, 13:655-663
Published Date: 26 November 2020
Should CYP2C19 Genotyping Be Recommended as a Straight Forward Approach to Optimize Clopidogrel Utilization in Patients with Ischemic Stroke Complicated by Type 2 Diabetes Mellitus?
Sun J, Leng P, Sun C, Xu W, Zhao Z, Li X, Zhang X, Li J
Pharmacogenomics and Personalized Medicine 2020, 13:645-653
Published Date: 23 November 2020
The Relationship Between Human Papillomavirus, OFD1 and Primary Ciliogenesis in the Progression of Oropharyngeal Cancer: A Retrospective Cohort Study
Meng H, Yang X, Liu R, Bao J, Hou Y, Sun J, Miao S, Qu G
Pharmacogenomics and Personalized Medicine 2020, 13:633-644
Published Date: 17 November 2020
Influence of PSRC1, CELSR2, and SORT1 Gene Polymorphisms on the Variability of Warfarin Dosage and Susceptibility to Cardiovascular Disease
AL-Eitan LN, Elsaqa BZ, Almasri AY, Aman HA, Khasawneh RH, Alghamdi MA
Pharmacogenomics and Personalized Medicine 2020, 13:619-632
Published Date: 17 November 2020
Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments
Bruera G, Ricevuto E
Pharmacogenomics and Personalized Medicine 2020, 13:601-617
Published Date: 16 November 2020
Association Between Cannabinoid Receptor-1 Gene Polymorphism and the Risk of Diabetic Nephropathy Among Patients with Type 2 Diabetes Mellitus
Zhang X, Zhu H, Xing X, Zhang C
Pharmacogenomics and Personalized Medicine 2020, 13:591-599
Published Date: 12 November 2020
P2RX7 Gene rs1718125 Polymorphism is Related with Postoperative Pain and Fentanyl Intake in Esophageal Cancer Patients
Zheng C, Wang J, Xie S
Pharmacogenomics and Personalized Medicine 2020, 13:585-589
Published Date: 12 November 2020
Functional Genetic Variation in the 3′-UTRNTRK2 is Associated with Risk of Ischemic Stroke
Shi J, Sun Y, Hua J
Pharmacogenomics and Personalized Medicine 2020, 13:577-584
Published Date: 12 November 2020
Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment
Habtemikael L, Russom M, Bahta I, Mihreteab S, Berhane A, Mårtensson A, Gil JP
Pharmacogenomics and Personalized Medicine 2020, 13:571-575
Published Date: 12 November 2020
Susceptibility of PON1/PON2 Genetic Variations to Ischemic Stroke Risk in a Chinese Han Population
Pan Y, He B, Sun H, Xu T, Pan B, Wang S, Mei Y
Pharmacogenomics and Personalized Medicine 2020, 13:563-570
Published Date: 29 October 2020
Sex-Specific Influence of the SCARB1 Rs5888 SNP on the Serum Lipid Response to Atorvastatin in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Wu DF, Lin D, Lu F, Liao QC, Wu YJ, Wang Z, Yu K, Li WJ, Deng JL
Pharmacogenomics and Personalized Medicine 2020, 13:553-561
Published Date: 29 October 2020
CYP2D6 Predicts Plasma Donepezil Concentrations in a Cohort of Thai Patients with Mild to Moderate Dementia
Chamnanphon M, Wainipitapong S, Wiwattarangkul T, Chuchuen P, Nissaipan K, Phaisal W, Tangwongchai S, Sukasem C, Wittayalertpanya S, Gaedigk A, Aniwattanapong D, Chariyavilaskul P
Pharmacogenomics and Personalized Medicine 2020, 13:543-551
Published Date: 2 November 2020
Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
Babayeva M, Loewy Z
Pharmacogenomics and Personalized Medicine 2020, 13:531-542
Published Date: 23 October 2020
SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population
Rattanacheeworn P, Chamnanphon M, Thongthip S, Kittanamongkolchai W, Townamchai N, Avihingsanon Y, Udomnilobol U, Prueksaritanont T, Jianmongkol S, Chariyavilaskul P
Pharmacogenomics and Personalized Medicine 2020, 13:521-530
Published Date: 22 October 2020
Immune Response-Related Genes – STAT4, IL8RA and CCR7 Polymorphisms in Lung Cancer: A Case–Control Study in China
Ma Y, Zhou Y, Zhang H, Su X
Pharmacogenomics and Personalized Medicine 2020, 13:511-519
Published Date: 21 October 2020
Genetic Association of Epilepsy and Anti-Epileptic Drugs Treatment in Jordanian Patients
AL-Eitan LN, Al-Dalala IM, Elshammari AK, Khreisat WH, Nimiri AF, Alnaamneh AH, Aljamal HA, Alghamdi MA
Pharmacogenomics and Personalized Medicine 2020, 13:503-510
Published Date: 16 October 2020
Identifying the Mechanisms and Molecular Targets of Yizhiqingxin Formula on Alzheimer’s Disease: Coupling Network Pharmacology with GEO Database
Zhang T, Pan L, Cao Y, Liu N, Wei W, Li H
Pharmacogenomics and Personalized Medicine 2020, 13:487-502
Published Date: 15 October 2020
A Variant of Leptin Gene Decreases the Risk of Gastric Cancer in Chinese Individuals: Evidence from a Case–Control Study [Corrigendum]
Ma R, He Q
Pharmacogenomics and Personalized Medicine 2020, 13:485-486
Published Date: 14 October 2020
Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease
Cafiero C, Re A, Micera A, Palmirotta R, Monaco D, Romano F, Fabrizio C, Di Francia R, Cacciamani A, Surico PL, D'Amato G, Pisconti S
Pharmacogenomics and Personalized Medicine 2020, 13:463-484
Published Date: 13 October 2020
Competing Endogenous RNA (ceRNA) Network Analysis of Autophagy-Related Genes in Hepatocellular Carcinoma
Yang C, Wang Y, Xue W, Xie Y, Dong Q, Zhu C
Pharmacogenomics and Personalized Medicine 2020, 13:445-462
Published Date: 13 October 2020
Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review
Afifah NN, Diantini A, Intania R, Abdulah R, Barliana MI
Pharmacogenomics and Personalized Medicine 2020, 13:427-444
Published Date: 8 October 2020
Comprehensive Evaluation of Endocytosis-Associated Protein SCAMP3 in Hepatocellular Carcinoma
Zhou A, Liu H, Tang B
Pharmacogenomics and Personalized Medicine 2020, 13:415-426
Published Date: 7 October 2020
Genetic Testing for BCHE Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to Succinylcholine
Zhu G, Dawson E, Huskey A, Gordon RJ, Del Tredici AL
Pharmacogenomics and Personalized Medicine 2020, 13:405-414
Published Date: 30 September 2020
A Variant of Leptin Gene Decreases the Risk of Gastric Cancer in Chinese Individuals: Evidence from a Case–Control Study
Ma R, He Q
Pharmacogenomics and Personalized Medicine 2020, 13:397-404
Published Date: 22 September 2020
Altered Gene Expression in Acne Vulgaris Patients Treated by Oral Isotretinoin: A Preliminary Study
Jiang Y, Chen H, Han L, Xie X, Zheng Y, Lai W
Pharmacogenomics and Personalized Medicine 2020, 13:385-395
Published Date: 15 September 2020
Carvedilol Alters Circulating MiR-1 and MiR-214 in Heart Failure
Shirazi-Tehrani E, Firouzabadi N, Tamaddon G, Bahramali E, Vafadar A
Pharmacogenomics and Personalized Medicine 2020, 13:375-383
Published Date: 3 September 2020
Prognostic Values of Radiosensitivity Genes and CD19 Status in Gastric Cancer: A Retrospective Study Using TCGA Database
Liang LB, Huang XY, He H, Liu JY
Pharmacogenomics and Personalized Medicine 2020, 13:365-373
Published Date: 8 September 2020
The Relationship Between Single Nucleotide Polymorphisms of SMAD3/SMAD6 and Risk of Esophageal Squamous Cell Carcinoma in Chinese Population
Yu J, Dong Y, Tang W, Pan H, Lv L, Long T, Zhou Q, Qi J, Liu J, Ding G, Yin J, Tan L
Pharmacogenomics and Personalized Medicine 2020, 13:355-363
Published Date: 24 August 2020
Variations in the Wnt/β-Catenin Pathway Key Genes as Predictors of Cervical Cancer Susceptibility [Corrigendum]
Wang B, Wang M, Li X, Yang M, Liu L
Pharmacogenomics and Personalized Medicine 2020, 13:353-354
Published Date: 24 August 2020
IKBKB rs2272736 is Associated with Gastric Cancer Survival
Gong Y, Zhao W, Jia Q, Dai J, Chen N, Chen Y, Gu D, Huo X, Chen J
Pharmacogenomics and Personalized Medicine 2020, 13:345-352
Published Date: 19 August 2020
IL-6 −572C>G and CARD8 304T>A Genetic Polymorphisms are Associated with the Absolute Neutrophil Count in Patients with Hematological Malignancies Under Chemotherapy: An Application of Multilevel Models to a Preliminary Pharmacogenetic Study
Martinez MF, Alveal E, Soto TG, Bustamante EI, Ávila F, Bangdiwala SI, Flores I, Benavides C, Morales R, Varela NM, Quiñones LA
Pharmacogenomics and Personalized Medicine 2020, 13:337-343
Published Date: 19 August 2020
Association Between Vitamin D Receptor Gene Polymorphism rs2228570 and Allergic Rhinitis
Zhang W, Xu Y
Pharmacogenomics and Personalized Medicine 2020, 13:327-335
Published Date: 17 August 2020
CHRM3 rs2165870 Polymorphism Correlates with Postoperative Nausea and Vomiting Incidence and the Efficacy of Ondansetron in a Chinese Han Population
Wang J, Li Y, Zheng C, Sun Y, Yang J
Pharmacogenomics and Personalized Medicine 2020, 13:319-326
Published Date: 13 August 2020
Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia
Maamari D, El-Khoury H, Saifi O, Muwakkit SA, Zgheib NK
Pharmacogenomics and Personalized Medicine 2020, 13:295-317
Published Date: 12 August 2020
CYP2D6 Expression in Veterans Experiencing Opioid Overdose: A Postmortem Review
Boyle J, Stock CJ
Pharmacogenomics and Personalized Medicine 2020, 13:289-293
Published Date: 11 August 2020
miR-100 rs1834306 A>G Increases the Risk of Hirschsprung Disease in Southern Chinese Children
Zhu Y, Lin A, Zheng Y, Xie X, He Q, Zhong W
Pharmacogenomics and Personalized Medicine 2020, 13:283-288
Published Date: 10 August 2020
Polymorphism of XRCC3 in Egyptian Breast Cancer Patients
Alkasaby MK, Abd El-Fattah AI, Ibrahim IH, Abd El-Samie HS
Pharmacogenomics and Personalized Medicine 2020, 13:273-282
Published Date: 6 August 2020
Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
Cazzola M, Rogliani P, Calzetta L, Matera MG
Pharmacogenomics and Personalized Medicine 2020, 13:261-271
Published Date: 4 August 2020
Genetic Polymorphisms in Transforming Growth Factor-β, Interferon-γ and Interleukin-6 Genes and Susceptibility to Behcet’s Disease in Saudi Population
Al Okaily F, Alrashidi S, Mustafa M, Alrashdan FB
Pharmacogenomics and Personalized Medicine 2020, 13:253-259
Published Date: 31 July 2020
Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence
Gower MN, Ratner LR, Williams AK, Rossi JS, Stouffer GA, Lee CR
Pharmacogenomics and Personalized Medicine 2020, 13:239-252
Published Date: 27 July 2020
Comparison of Patient Susceptibility Genes Across Breast Cancer: Implications for Prognosis and Therapeutic Outcomes
Peleg Hasson S, Menes T, Sonnenblick A
Pharmacogenomics and Personalized Medicine 2020, 13:227-238
Published Date: 27 July 2020
Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network
Duong BQ, Arwood MJ, Hicks JK, Beitelshees AL, Franchi F, Houder JT, Limdi NA, Cook KJ, Owusu Obeng A, Petry N, Tuteja S, Elsey AR, Cavallari LH, Wiisanen K
Pharmacogenomics and Personalized Medicine 2020, 13:217-226
Published Date: 17 July 2020
Analysis of Comprehensive Pharmacogenomic Profiling of VIP Variants Among the Genetically Isolated Chechen Subpopulation from Jordan
AL-Eitan LN, Rababa'h DM, Hakooz NM, Alghamdi MA, Dajani RB
Pharmacogenomics and Personalized Medicine 2020, 13:199-215
Published Date: 14 July 2020
Association Study of MAP3K1 SNPs and Risk Factors with Susceptibility to Esophageal Squamous Cell Carcinoma in a Chinese Population: A Case–Control Study
Yang Y, Zhou Q, Pan H, Wang L, Qian C
Pharmacogenomics and Personalized Medicine 2020, 13:189-197
Published Date: 3 July 2020
Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients
Wu X, Xu QJ, Chen PZ, Yu CB, Ye LF, Li T
Pharmacogenomics and Personalized Medicine 2020, 13:181-188
Published Date: 4 June 2020
Single Nucleotide Variants Associated with Colorectal Cancer Among Iranian Patients: A Narrative Review
Jamshidi M, Mohammadi Pour S, Mahmoudian-Sani MR
Pharmacogenomics and Personalized Medicine 2020, 13:167-180
Published Date: 3 June 2020
Variations in the Wnt/β-Catenin Pathway Key Genes as Predictors of Cervical Cancer Susceptibility
Wang B, Wang M, Li X, Yang M, Liu L
Pharmacogenomics and Personalized Medicine 2020, 13:157-165
Published Date: 20 May 2020
Negative Association Between lncRNA HOTTIP rs3807598 C>G and Hirschsprung Disease
Zheng Y, Zhuo Z, Xie X, Lu L, He Q, Zhong W
Pharmacogenomics and Personalized Medicine 2020, 13:151-156
Published Date: 6 May 2020
Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy
Zhang C, Duan S, Guo M, Yuan Y, Huang Z, Zhu J, Sun B, Zhang B, Xing C
Pharmacogenomics and Personalized Medicine 2020, 13:141-149
Published Date: 23 April 2020
Challenges and Future Prospects of Precision Medicine in Psychiatry
Manchia M, Pisanu C, Squassina A, Carpiniello B
Pharmacogenomics and Personalized Medicine 2020, 13:127-140
Published Date: 23 April 2020
Association Between lncRNA HULC rs7763881 Polymorphism and Gastric Cancer Risk
Hong JH, Jin EH, Chang IA, Kang H, Lee SI, Sung JK
Pharmacogenomics and Personalized Medicine 2020, 13:121-126
Published Date: 9 April 2020
On the Role of Artificial Intelligence in Genomics to Enhance Precision Medicine
Álvarez-Machancoses Ó, DeAndrés Galiana EJ, Cernea A, Fernández de la Viña J, Fernández-Martínez JL
Pharmacogenomics and Personalized Medicine 2020, 13:105-119
Published Date: 19 March 2020
Pharmacogenetics of Pediatric Asthma: Current Perspectives
Perez-Garcia J, Espuela-Ortiz A, Lorenzo-Diaz F, Pino-Yanes M
Pharmacogenomics and Personalized Medicine 2020, 13:89-103
Published Date: 18 March 2020
ADAM17 Genetic Variants and the Response of TNF-α Inhibitor in Rheumatoid Arthritis Patients
Kim HJ, Trinh NT, Choi Y, Kim W, Min KH, Kang SO, Kim JH, Kim HA, Jung JY, Choi IA, Lee KE
Pharmacogenomics and Personalized Medicine 2020, 13:81-88
Published Date: 16 March 2020
Sex Differences in Associations Between CYP2D6 Phenotypes and Response to Opioid Analgesics
Lopes GS, Bielinski SJ, Moyer AM, Black III JL, Jacobson DJ, Jiang R, Larson NB, St Sauver JL
Pharmacogenomics and Personalized Medicine 2020, 13:71-79
Published Date: 13 March 2020
A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions
Calderon-Ospina CA, Hernández-Sómerson M, García AM, Mejia A, Tamayo-Agudelo C, Laissue P, Fonseca Mendoza DJ
Pharmacogenomics and Personalized Medicine 2020, 13:59-70
Published Date: 2 March 2020
HMGA2 Polymorphisms and Hepatoblastoma Susceptibility: A Five-Center Case-Control Study
Li L, Zhuo Z, Yang Z, Zhu J, He X, Yang Z, Zhang J, Xin Y, He J, Zhang T
Pharmacogenomics and Personalized Medicine 2020, 13:51-57
Published Date: 11 February 2020
Towards Precision Medicine in Systemic Lupus Erythematosus
Lever E, Alves MR, Isenberg DA
Pharmacogenomics and Personalized Medicine 2020, 13:39-49
Published Date: 4 February 2020
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
Sychev DA, Baturina OA, Mirzaev KB, Rytkin E, Ivashchenko DV, Andreev DA, Ryzhikova KA, Grishina EA, Bochkov PO, Shevchenko RV
Pharmacogenomics and Personalized Medicine 2020, 13:29-37
Published Date: 23 January 2020
The Effect of UGT1A9, CYP2B6 and CYP2C9 Genes Polymorphism on Propofol Pharmacokinetics in Children
Pavlovic D, Budic I, Jevtovic Stoimenov T, Stokanovic D, Marjanovic V, Stevic M, Slavkovic M, Simic D
Pharmacogenomics and Personalized Medicine 2020, 13:13-27
Published Date: 17 January 2020
Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
Chamnanphon M, Gaedigk A, Puangpetch A, Pasomsub E, Chantratita W, Longley RJ, Sattabongkot J, Chariyavilaskul P, Sukasem C
Pharmacogenomics and Personalized Medicine 2020, 13:1-12
Published Date: 10 January 2020